About this trial
The aim of this exploratory randomized controlled clinical study is to evaluate the health-promoting effects of Kneipp hydrotherapy, in the form of the Vital Shower in a four-week daily application.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Female and male patients between 18 and 70 years of age
Disqualifiers
Bad general condition
Serious acute or chronic comorbidity
Pregnancy and breast feeding period/ in the next 6 months
Participation in a clinical trial within the last 3 months before enrollment
Trial design
Parallel
Treatments tested in this trial
Hansgrohe prototype/shower head
DeviceStart of the shower with warm comfort temperature and usual body cleansing. Then the Vital shower is carried out for a total of 3-5 minutes, followed optionally by another warm shower with 30 seconds or direct transition to a classic cold shower for 30- 60 seconds
Treatment groups
Trial outcomes
Primary outcomes
Immunological laboratory
T-Cells (CD3), B-Cells (CD19), Natural Killer Cells (CD16), T-helper cells (CD4), cytotoxic T-cells (CD8), CD4/CD8 ratio, interleukin 4, interferon gamma
Blood pressure at rest (systolic and diastolic)
Hospital Anxiety and Depression Scale (HADS-D)
Change
Self-Efficacy Scale (ASKU)
Change
Sponsors and contacts
Click on the lead sponsor to view all of their trials.